Fulphila

Indicated For

neutropenia,febrile neutropenia

About This Medication

# Biocon Biologics Patient Assistance Program Patient Guide: How to Get Fulphila (pegfilgrastim-jmdb) at Low or No Cost Fulphila (pegfilgrastim-jmdb) is a biosimilar leukocyte growth factor injection used to decrease the risk of infection from febrile neutropenia in patients with non-myeloid malignancies receiving myelosuppressive chemotherapy.[7] The **Biocon Biologics Patient Assistance Program** provides **free medication** to uninsured or low-income patients who cannot afford it, helping bridge the gap for those facing high costs.[2][3] ## About Fulphila (pegfilgrastim-jmdb) **Fulphila** is a clear, colorless solution in a prefilled single-dose syringe (6 mg/0.6 mL) administered subcutaneously once per chemotherapy cycle, typically on day 2.[7] It works like pegfilgrastim by stimulating white blood cell production to reduce severe neutropenia duration, lowering infection risk during chemotherapy. As a biosimilar to Neulasta, it offers comparable efficacy at potentially lower cost.[7] Common side effects include bone pain, back pain, and fatigue; monitor complete blood counts (CBC) for leukocytosis (WBC >100 x 10^9/L).[7] Always consult your doctor for personalized advice. ## Who Qualifies? This program targets **uninsured or low-income patients** unable to afford Fulphila.[2][3] Specific income thresholds are not publicly detailed but emphasize financial need—free medication for those who qualify.[2] Alternative programs like Prescription Hope suggest guidelines around $50,000 for individuals, $70,000 for households (up to $200,000 for larger families), though Biocon's criteria may vary.[1] No strict Federal Poverty Level (FPL) percentage is specified; eligibility focuses on demonstrated inability to pay.[2] ## Income Eligibility Breakdown | Household Size | Approximate Annual Income Guideline (Reference: Similar Programs)[1] | Notes | |---------------|---------------------------------------------------------------|-------| | Individual | Up to ~$50,000 | Biocon: Based on financial need; exact thresholds not listed[2] | | Couple/Household | Up to ~$70,000 | May increase for larger families up to ~$200,000[1] | | Family of 3 | Flexible, need-based | Free for those who cannot afford[2] | | Family of 4+ | Up to ~$200,000 possible | Proof of income required; consult program[1][2] | **Notes**: Biocon does not publish exact figures; apply to confirm. Guidelines adjust for family size and location.[1][2] ## Insurance Requirements The program is for **uninsured or low-income patients**.[2][3] It does not typically cover those with comprehensive insurance, but may assist if coverage leaves high out-of-pocket costs. Medicare Part D enrollees should check Extra Help (low-income subsidy) first, as some PAPs exclude Medicare recipients.[4] Prescription Hope notes it works alongside insurance without copays/deductibles, but Biocon specifies uninsured/low-income.[1][3][4] ## Step-by-Step Application Process 1. **Verify Eligibility**: Confirm uninsured/low-income status and doctor's prescription for Fulphila.[3] 2. **Download Forms**: Get the **Patient Enrollment Form** from the official portal: [application link provided in program details].[3] 3. **Gather Documents**: Prepare the Patient Enrollment Form; additional proof like income statements or insurance denial may be needed.[3] 4. **Complete and Submit**: Fill out with patient, doctor, and pharmacy info. Request support for Fulphila 6 mg/0.6 mL injection.[3] Multiple application methods available (e.g., download/fax/mail).[2] 5. **Doctor Involvement**: Your healthcare provider must sign and submit clinical details.[3] 6. **Follow Up**: Track status via portal or contact Biocon.[2] ## Timeline and Delivery Processing time not specified; similar programs deliver first order in **2-4 weeks** after paperwork.[1] Medication ships free to your home or pharmacy—details confirmed post-approval.[2] Refills managed ongoing if eligible.[1] ## Biosimilar Alternatives if Denied If ineligible, consider these **pegfilgrastim biosimilars** (often prior-authorized similarly):[5] - **Neulasta** (reference) - **Udenyca** (pegfilgrastim-cbqv) - **Nyvepria** - **Ziextenzo** Explore Prescription Hope ($60/month flat) or Medicare Extra Help/State programs.[1][4] GoodRx for coupons; manufacturer PAPs for alternatives.[4] ## Important Disclaimer This guide is for informational purposes only and not medical/financial advice. Eligibility, terms, and availability can change—verify directly with Biocon Biologics.[2][3] Consult your healthcare provider before starting Fulphila. Program excludes those with ability to pay; false info may disqualify. For latest details, use official application.[1][2][3][7] (Word count: 912)

Program information last verified: March 30, 2026